Study to Evaluate DNL151 in Subjects With Parkinson's Disease
NCT04056689
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson's Disease
Interventions
DRUG:
DNL151
DRUG:
Placebo
Sponsor
Biogen